Ellsworth Advisors, LLC Fulgent Genetics, Inc. Transaction History

Ellsworth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$66.8 - $100.45 $602,268 - $905,657	-9,016 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$59.3 - $183.85 $25,143 - $77,952	424 Added 4.93%	9,016 $871,000
Q4 2020 Feb 03, 2021	BUY	$31.01 - $52.1 $41,522 - $69,761	1,339 Added 18.46%	8,592 $448,000
Q3 2020 Feb 03, 2021	BUY	$15.89 - $50.51 $115,250 - $366,349	7,253 New	7,253 $290,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.